Georg Duenstl, Ph.D​.

VP of Drug Discovery

Having served on DeepCure’s Scientific Advisory Board since its inception in 2018, Georg joined the company as Vice President of Drug Discovery in 2022. He has over 16 years of drug discovery experience emphasizing pharmacology, strategy, and innovation. Before joining DeepCure, Georg was an Associate Research Fellow at LEO Pharma. He worked for more than 13 years in various positions at the company’s Danish headquarters and its Boston-based Science & Tech Hub, where he served as Chief Scientist. Georg studied in Germany and the US and holds a Ph.D. in Biochemical Pharmacology and MSc in Biology from the University of Konstanz. He also completed advanced executive education programs at the Wharton School of the University of Pennsylvania (CPD) and the MIT Sloan School of Management (ACE).